ロード中...
A novel oncolytic adenovirus based on simian adenovirus serotype 24
Among the oncolytic virotherapy, an emerging treatment for tumor, adenoviruses are widely used at present in preclinical and clinical trials. Traditionally, oncolytic adenoviruses were developed based on the human adenovirus serotype 5 (AdHu5). However, AdHu5 has the drawbacks of preexisting anti-Ad...
保存先:
| 出版年: | Oncotarget |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Impact Journals LLC
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5432303/ https://ncbi.nlm.nih.gov/pubmed/28460470 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.15845 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|